Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
κ-opioid receptor - Wikipedia
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
PDF) Major Depressive Disorder and Kappa Opioid Receptor Antagonists
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Opioid Agonists and Antagonists | Anesthesia Key
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Development of κ opioid receptor antagonists. | Semantic Scholar
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opioids, Salvinorin A and Major Depressive Disorder
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Dynorphin, stress, and depression | Semantic Scholar
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors | ACS Chemical Neuroscience
κ-opioid receptor - Wikipedia
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
